Diskussionsleitung: B. Osswald (Duisburg), R. H. G. Schwinger (Weiden i. d. Oberpfalz)
| (P2193) | Use of SGLT-2 Inhibitors and Sacubitril/Valsartan in Patients with Congenital Heart Disease: A Nationwide Analysis based on 1,049 treated Patients | |
| M. L. Benesch Vidal, S. Orwat, R. Schmidt, R. M. Radke, F. De Torres-Alba, G. Kaleschke, U. Marschall, U. Bauer, E. Bormann, H. Baumgartner, G. P. Diller (Münster, Wuppertal, Berlin) | ||
| (P2194) | Changes in left ventricular strain under SGLT-2 inhibitor in patients with HFrEF | |
| C. Öztürk, E. Mittag, G. Nickenig, M. Weber, C. Hammerstingl (Bonn, Köln) | ||
| (P2195) | Impact on hepatic and blood gas analysis parameters in patients with acute decompensated heart failure treated with empagliflozin – A secondary analysis of the EMPAG-HF trial | |
| J. Bogoviku, J. G. Westphal, P. Aftanski, F. Härtel, S. Grund, S. von Haehling, M. Busch, S. Möbius-Winkler, C. Schulze (Jena, Göttingen) | ||
| (P2196) | Inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway modulate the increased mortality risk in patients with HFrEF and clonal hematopoiesis of indeterminate potential | |
| S. Cremer, N. Katsaouni, W. Abplanalp, A. Berkowitsch, K. Kirschbaum, M. Rieger, S. Rapp, P. S. Wild, S. Dimmeler, M. Schulz, A. M. Zeiher (Frankfurt am Main, Bad Nauheim, Mainz) | ||
| (P2197) | Immature platelets (IP) in patients with reduced ventricular function. First results of the PRISCA study | |
| J. Blaudischek, A. Kille, K. Franke, N. Corpataux, A. Vömel, P. M. Dinse, D. Quack, P. Ludwig, D. Westermann, T. Nührenberg, W. Hochholzer (Bad Krozingen, Würzburg; Bern, CH) | ||
| (P2198) | Effector T cell chemokine CXCL10 / IP-10 levels predict left ventricular function recovery and cardiovascular outcomes after ST-elevation myocardial infarction | |
| K. Sopova, S. Tual-Chalot, M. Müller-Hennessen, M. Sachse, M. Biener, M. Amponsah-Offeh, G. Ciliberti, E. Giannitsis, I. Spyridopoulos, K. Stellos (Mannheim, Heidelberg, Hamburg; Newcastle Upon Tyne, UK) | ||
| (P2199) | Proteomic signature of the Poincaré plot index (SD1/SD2) of heart rate variability and its pathophysiological relevance in the heart failure syndrome – Results from the MyoVasc Study | |
| S. Zeid, G. Buch, T. Koeck, D. Velmeden, J. Söhne, V. ten Cate, S. Rapp, A. Schulz, A. Schuch, M. Heidorn, F. Müller, K. Leineweber, K. Lackner, T. Münzel, J. Prochaska, P. S. Wild (Mainz, Wuppertal) | ||
| (P2200) | Candidate screening of multi-omic indicators with cardiometabolic relevance for severe clinical disease courses of COVID-19 | |
| A. Dutsch, C. Uhlig, M. Bock, C. Gräßer, S. Schuchardt, S. Uhlig, H. Schunkert, M. Joner, S. Holdenrieder, K. Lechner (München, Hannover, Berlin) |